ECAL Study

Full title: Effectiveness of Electronic Cigarettes compared with combination nicotine replacement therapy for smoking cessation in patients with chronic obstructive pulmonary disease And effect on Lung health (ECAL trial)

The main objective of this study is to find out how effective e-cigs are compared with combination nicotine replacement therapy (NRT) in helping Chronic Obstructive Pulmonary Disease (COPD) patients quit smoking cigarettes, and which treatment is more cost-effective for the National Health Service (NHS). 

Along with the main objective, the study also has a lung health sub-study that aims investigate the effect of switching from smoking to exclusive EC use on clinical, physiological and cellular lung health measures compared with (1) quitting smoking without vaping and (2) continuing to smoke in patients with COPD. 

Wellbeing sub-study aims and objectives: To investigate the effect of switching from smoking to exclusive EC use on anxiety, depression and social quality of life compared with (1) quitting smoking without vaping and (2) continuing to smoke in patients with COPD.   

For more information or if you are interested in the study please follow this link CLICK HERE